Abstract:Introduction Heart failure (HF) is associated with significant morbidity, mortality, and health care costs. Stage B HF is defined as structural heart disease prior to developing symptomatic HF. If identified early in the disease process, preventative measures may be implemented to slow disease progression to Stage C (symptomatic) or Stage D (refractory) HF. Previous research has focused on outpatient screening for HF in the primary care setting; however, there are limited data on Stage B HF screening in the Emergency Department (ED) setting. The objective of this study was to determine the prevalence of undiagnosed Stage B HF among those with cardiovascular risk factors in the ED setting and identify which risk factors were associated with a greater risk of having Stage B HF. Methods A prospective, observational study was performed in a single, urban academic ED from 07/2023 to 05/2024. Inclusion criteria were age ≥ 45 years with hypertension, diabetes, obesity, coronary heart disease, previous cardiotoxic chemotherapy, or family history of HF. Exclusion criteria included signs or symptoms of HF, known history of HF, valvular disease, current atrial fibrillation, or primary language other than English. A focused cardiac ultrasound was performed and interpreted by ultrasound-fellowship trained emergency physicians. Sonographers assessed systolic function as ejection fraction <50 % using visual assessment in at least two different views. Sonographers assessed diastolic dysfunction as an E/A ratio < 0.8, or if ≥2 of the following were present: septal e' < 7 cm/s or lateral e' 14, or left atrial volume > 34 mL/m 2 . Descriptive statistics were performed, followed by comparative analyses and regression modeling. Results 209 participants were included in the study, with a mean age of 60 years and 51.7 % women. Of these, 125 (59.8 %) had undiagnosed Stage B HF, with 13 (10.4 %) having systolic dysfunction and 112 (89.6 %) having isolated diastolic dysfunction. Among those with isolated diastolic dysfunction, 44 (39.3 %) were grade I, 66 (58.9 %) were grade II, and 2 (1.8 %) were grade III. Predictors of undiagnosed Stage B HF included age (odds ratio 1.06; 95 % CI 1.02 to 1.10) and BMI (odds ratio 1.06; 95 % CI 1.01 to 1.10). Conclusion A large majority of ED patients with cardiovascular risk factors had undiagnosed Stage B HF. Age and obesity were associated with a higher risk of Stage B HF. This provides an opportunity for early identification and intervention for patients with undiagnosed Stage B HF to reduce progression to more severe HF.

Emergency Department Use of Heart Failure-Exacerbating Medications in Patients with Chronic Heart Failure

Prescribing Patterns of Heart Failure-Exacerbating Medications Following a Heart Failure Hospitalization.

Epidemiology of heart failure presentations to United States emergency departments from 2016 to 2023

HEART FAILURE-EXACERBATING MEDICATION USE IS COMMON BOTH BEFORE AND AFTER A HEART FAILURE HOSPITALIZATION

Systems of care for ambulatory management of decompensated heart failure

The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure

From Hospital to Home: Evidence-Based Care for Worsening Heart Failure

Remote management of worsening heart failure events and subsequent rate of emergency department admission

Acute heart failure: current pharmacological treatment and perspectives

Understanding social risk factors in patients presenting to the emergency Department for Acute Heart Failure: A pilot study

A multidisciplinary approach to heart failure care in the hospital: improving the patient journey

New models for heart failure care delivery

Evolving therapies for the management of chronic and acute decompensated heart failure

Emerging devices for heart failure management

Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper

Characteristics, Management, and Outcomes of Acute Heart Failure in the Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in Beijing.

Epidemiology and Management of Patients With Kidney Disease and Heart Failure With Preserved Ejection Fraction

Analysis of Worsening Heart Failure Events in an Integrated Health Care System

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events

Prevalence of undiagnosed stage B heart failure among emergency department patients

Poor Medication Access as a Driver of Excess Heart Failure Readmissions Among Patients Living in Economically Deprived Neighborhoods